Alan Kadish
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alan Kadish has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
J. Goldberger
6 shared publicationsD. Bello
3 shared publicationsD. Fieno
3 shared publicationsE. Shaoulian
3 shared publicationsJ. Narula
3 shared publicationsK. Shivkumar
3 shared publications
Latest Publications
- 1 March 2007
- Published by BMJ in Journal of Investigative Medicine
- Vol. 55 (2) , S351.2-S351
20 UNIQUE PARASYMPATHETIC PROFILE OF THE PULMONARY VEINS AND POSTERIOR LEFT ATRIUM.
Background The pulmonary veins (PVs) have recently been shown to play a major role in the genesis of atrial fibrillation (AF). Focal “triggers” and “drivers” in the PV appear to be significantly modified or regulated by the parasympathetic nervous system. Nonetheless, the detailed autonomic profile of the PVs-especially as it compares with the posterior left atrium (PLA) and the rest of the left atrium-has not been well characterized. We hypothesized that the left atrium exhibits a heterogeneous electrophysiologic response to autonomic maneuvers, with the activation and repolarization characteristics of the PVs being different from the rest of the left atrium. Since IKAch is the ion channel that is primarily responsible for vagal effects on left atrial refractoriness, we further hypothesized that interregional variation in repolarization (in response to vagal maneuvers) is due to differences in the expression and spatial distribution of IKAch within the PVs, PLA, and left atrial appendage (LAA). Methods In 14 dogs, high-density plaques were sutured onto the left inferior PV (8 × 5 electrodes), the PLA (7 × 3 electrodes), and LAA (7 × 3 electrodes) for bipolar electrogram recording and pacing. Epicardial mapping was performed in the PVs, PLA, and LAA under the following conditions: baseline, 20 Hz cervical vagal stimulation (VS), propranolol (P), P + VS, and P + atropine. Effective refractory periods (ERPs) were measured and conduction vectors were computed at multiple sites. Western blotting and immunostaining were performed for IKAch (Kir3.1/3.4). Results In response to VS, there was a significant decrease in ERP (9%) in the PV compared with baseline (p = .001). In contrast, ERP changes in the PLA and LAA in response to VS were not as pronounced. In the presence of beta-blockade, vagal stimulation (P + VS) resulted in a more pronounced decrease in ERP in the PV (17.7%), PLA (19.9%), and LAA (11.6%) (P + VS vs P − PV: p < .001, PLA: p = .003, LAA: p = .036) compared with VS alone. ERP decrease in the PV and PLA was significantly greater than in the LAA (p < .05). Cumulative vagal effect (ERP difference between P + VS and P + ATR) was found to be greatest in the LAA (ERP change: LAA > PV, p = .04; LAA > PLA, p = .12). The cumulative vagal effect in the PV, PLA, and LAA corresponded to the relative expression of the IKAch subunits Kir3.1 and Kir3.4 in these regions (for both Kir3.1 and 3.4, LAA > PLA > PV). However, vagal-induced ERP shortening was significantly more heterogeneous in the PLA compared with the LAA (variance of ERP shortening: PLA > LAA, p = .04). Heterogeneity of ERP shortening corresponded to the heterogeneity of IKAch distribution in each region (variance of the number of Kir3.1-positive cells counted under six high-power (40×) fields: PV = PLA > > LAA, p < .01). With VS and/or P, there was evidence of regional conduction delay in the PVs with a significant change in activation direction. Similar activation changes were not seen in the PLA and LAA. Conclusions The PVs and PLA demonstrate unique activation and repolarization characteristics in response to autonomic manipulation. The heterogeneity of vagal responses correlates with the pattern of IKAch distribution in the left atrium. The peculiar autonomic characteristics of the PVs and PLA may create substrate for reentry and atrial fibrillation.
- 1 March 2007
- Published by BMJ in Journal of Investigative Medicine
- Vol. 55 (2) , S351.2-S351
20 UNIQUE PARASYMPATHETIC PROFILE OF THE PULMONARY VEINS AND POSTERIOR LEFT ATRIUM.
Background The pulmonary veins (PVs) have recently been shown to play a major role in the genesis of atrial fibrillation (AF). Focal “triggers” and “drivers” in the PV appear to be significantly modified or regulated by the parasympathetic nervous system. Nonetheless, the detailed autonomic profile of the PVs-especially as it compares with the posterior left atrium (PLA) and the rest of the left atrium-has not been well characterized. We hypothesized that the left atrium exhibits a heterogeneous electrophysiologic response to autonomic maneuvers, with the activation and repolarization characteristics of the PVs being different from the rest of the left atrium. Since IKAch is the ion channel that is primarily responsible for vagal effects on left atrial refractoriness, we further hypothesized that interregional variation in repolarization (in response to vagal maneuvers) is due to differences in the expression and spatial distribution of IKAch within the PVs, PLA, and left atrial appendage (LAA). Methods In 14 dogs, high-density plaques were sutured onto the left inferior PV (8 × 5 electrodes), the PLA (7 × 3 electrodes), and LAA (7 × 3 electrodes) for bipolar electrogram recording and pacing. Epicardial mapping was performed in the PVs, PLA, and LAA under the following conditions: baseline, 20 Hz cervical vagal stimulation (VS), propranolol (P), P + VS, and P + atropine. Effective refractory periods (ERPs) were measured and conduction vectors were computed at multiple sites. Western blotting and immunostaining were performed for IKAch (Kir3.1/3.4). Results In response to VS, there was a significant decrease in ERP (9%) in the PV compared with baseline (p = .001). In contrast, ERP changes in the PLA and LAA in response to VS were not as pronounced. In the presence of beta-blockade, vagal stimulation (P + VS) resulted in a more pronounced decrease in ERP in the PV (17.7%), PLA (19.9%), and LAA (11.6%) (P + VS vs P − PV: p < .001, PLA: p = .003, LAA: p = .036) compared with VS alone. ERP decrease in the PV and PLA was significantly greater than in the LAA (p < .05). Cumulative vagal effect (ERP difference between P + VS and P + ATR) was found to be greatest in the LAA (ERP change: LAA > PV, p = .04; LAA > PLA, p = .12). The cumulative vagal effect in the PV, PLA, and LAA corresponded to the relative expression of the IKAch subunits Kir3.1 and Kir3.4 in these regions (for both Kir3.1 and 3.4, LAA > PLA > PV). However, vagal-induced ERP shortening was significantly more heterogeneous in the PLA compared with the LAA (variance of ERP shortening: PLA > LAA, p = .04). Heterogeneity of ERP shortening corresponded to the heterogeneity of IKAch distribution in each region (variance of the number of Kir3.1-positive cells counted under six high-power (40×) fields: PV = PLA > > LAA, p < .01). With VS and/or P, there was evidence of regional conduction delay in the PVs with a significant change in activation direction. Similar activation changes were not seen in the PLA and LAA. Conclusions The PVs and PLA demonstrate unique activation and repolarization characteristics in response to autonomic manipulation. The heterogeneity of vagal responses correlates with the pattern of IKAch distribution in the left atrium. The peculiar autonomic characteristics of the PVs and PLA may create substrate for reentry and atrial fibrillation.
- 1 March 2007
- Published by BMJ in Journal of Investigative Medicine
- Vol. 55 (2) , S351
UNIQUE PARASYMPATHETIC PROFILE OF THE PULMONARY VEINS AND POSTERIOR LEFT ATRIUM.
- 1 March 2007
- Published by BMJ in Journal of Investigative Medicine
- Vol. 55 (2) , S351
UNIQUE PARASYMPATHETIC PROFILE OF THE PULMONARY VEINS AND POSTERIOR LEFT ATRIUM.
- 1 January 2005
- Published by BMJ in Journal of Investigative Medicine
- Vol. 53 (1) , S122.3-S122
254 CARDIAC MRI: COMPARISON OF INFARCT SIZE BY QUANTITATIVE PLANIMETRY VERSUS A QUALITATIVE VISUAL SCORING METHOD
- 1 January 2005
- Published by BMJ in Journal of Investigative Medicine
- Vol. 53 (1) , S122.3-S122
254 CARDIAC MRI: COMPARISON OF INFARCT SIZE BY QUANTITATIVE PLANIMETRY VERSUS A QUALITATIVE VISUAL SCORING METHOD
- 1 January 2005
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 53 (1) , S122.4-S122
255 CARDIAC MRI: DETECTION OF MI IN ISCHEMIC, NONISCHEMIC, AND MIXED CARDIOMYOPATHY:
- 1 January 2005
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 53 (1) , S122.4-S122
255 CARDIAC MRI: DETECTION OF MI IN ISCHEMIC, NONISCHEMIC, AND MIXED CARDIOMYOPATHY:
- 1 January 2005
- Published by BMJ in Journal of Investigative Medicine
- Vol. 53 (1) , S122.2-S122
253 CARDIAC MRI: INFARCT SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE
- 1 January 2005
- Published by BMJ in Journal of Investigative Medicine
- Vol. 53 (1) , S122.2-S122
253 CARDIAC MRI: INFARCT SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE
- 1 March 2004
- Published by BMJ in Journal of Investigative Medicine
- Vol. 52, S349
REGIONAL DISTRIBUTION OF DEPOLARIZATION ALTERNANS PRECEDING VF ONSET IN A CANINE ISCHEMIC MODEL.
- 1 March 2004
- Published by BMJ in Journal of Investigative Medicine
- Vol. 52, S349
REGIONAL DISTRIBUTION OF DEPOLARIZATION ALTERNANS PRECEDING VF ONSET IN A CANINE ISCHEMIC MODEL.
- 1 January 2001
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (2) , 163-167
Effects of age and gender on the QT response to exercise
- 1 January 2001
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (2) , 163-167
Effects of age and gender on the QT response to exercise
- 1 March 2000
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 23 (3) , 338-343
Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation
The Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) is a multicenter randomized trial. Patients will have nonischemic Cardiomyopathy (LVEF ± 35%), a history of symptomatic heart fail‐ure and spontaneous arrhythmia (> 10 PVCs/hour or nonsustained ventricular tachycardia defined as 3‐15 beats at a rate of > 120 beats/min) on Holter monitor or telemetry within the past 6 months. Patients will be randomized to an implantable cardioverter defibrillator (ICD) versus no ICD. All patients will re‐ceive standard oral medical therapy for heart failure including angiotensin converting enzyme inhibitors and β‐blockers (if tolerated). Patients will be followed for 2‐3 years. The primary endpoint will be total mortality. Quality‐of‐life and pharmacoeconomics analyses will also be performed. A registry will track patients who meet basic inclusion criteria but are not randomized. We estimate an annual total mortality of 15% at 2 years in the treatment arm that does not receive an ICD. The ICD is expected to reduce mor‐tality by 50%. Approximately 204 patients will be required in each treatment group. Twenty‐five centers will be included in a trial designed to last an estimated 4 years.
- 1 March 2000
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 23 (3) , 338-343
Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation
The Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) is a multicenter randomized trial. Patients will have nonischemic Cardiomyopathy (LVEF ± 35%), a history of symptomatic heart fail‐ure and spontaneous arrhythmia (> 10 PVCs/hour or nonsustained ventricular tachycardia defined as 3‐15 beats at a rate of > 120 beats/min) on Holter monitor or telemetry within the past 6 months. Patients will be randomized to an implantable cardioverter defibrillator (ICD) versus no ICD. All patients will re‐ceive standard oral medical therapy for heart failure including angiotensin converting enzyme inhibitors and β‐blockers (if tolerated). Patients will be followed for 2‐3 years. The primary endpoint will be total mortality. Quality‐of‐life and pharmacoeconomics analyses will also be performed. A registry will track patients who meet basic inclusion criteria but are not randomized. We estimate an annual total mortality of 15% at 2 years in the treatment arm that does not receive an ICD. The ICD is expected to reduce mor‐tality by 50%. Approximately 204 patients will be required in each treatment group. Twenty‐five centers will be included in a trial designed to last an estimated 4 years.
- 1 February 2000
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 23 (2) , 243-252
Effect of Underlying Heart Disease on the Frequency Content of Ventricular Fibrillation in the Dog Heart
Although prior studies have examined the frequency content of heal electro‐gram characteristics during fibrillation, little is know about the effects of underlying heart disease on these parameters. This study was designed to compare the frequency content of local electrograms during VF in canine models of acute ischemia, subacute infarction, and chronic myocardial infarction (MI) to those in control animals to test the hypothesis that underlying heart disease can alter the basic characteristics of VF. VF was induced using burst pacing in three groups of mongrel dogs. Five dogs were evaluated 8 weeks after LAD occlusion MI, five were evaluated 5 days after experimental MI, and 5 had VF induced before (control) and immediately after LAD occlusion (ischemia). During VF, unipolar electrograms were recorded from 112 sites on the anterior LV and electrograms were evaluated 15 and 30 seconds after VF initiation in each group. Electrograms were analyzed by fast Fourier transform. No significant time dependent changes in VF characteristics were noted. The peak frequency was highest in control animals and 8‐week MI, intermediate in 5‐day MI, and lowest in acute ischemia (P < 0.01 for pairwise comparisons). In contrast, the fractional of energy within a bandwidth of 25% peak amplitude was highest in acute ischemia, (P < 0.001) and similar in the other three groups. Infarction decreased total energy by approximately 50%. In conclusion, the pressure of ischemia or infarction alters the frequency content of VF in a complex fashion. In addition to decreasing the peak frequency, the shape of the power spectral curve is altered in models of structural heart disease. These results suggest that the electrophysiological changes produced by infarction or ischemia alter the structural organization of ventricular fibrillation.
- 1 February 2000
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 23 (2) , 243-252
Effect of Underlying Heart Disease on the Frequency Content of Ventricular Fibrillation in the Dog Heart
Although prior studies have examined the frequency content of heal electro‐gram characteristics during fibrillation, little is know about the effects of underlying heart disease on these parameters. This study was designed to compare the frequency content of local electrograms during VF in canine models of acute ischemia, subacute infarction, and chronic myocardial infarction (MI) to those in control animals to test the hypothesis that underlying heart disease can alter the basic characteristics of VF. VF was induced using burst pacing in three groups of mongrel dogs. Five dogs were evaluated 8 weeks after LAD occlusion MI, five were evaluated 5 days after experimental MI, and 5 had VF induced before (control) and immediately after LAD occlusion (ischemia). During VF, unipolar electrograms were recorded from 112 sites on the anterior LV and electrograms were evaluated 15 and 30 seconds after VF initiation in each group. Electrograms were analyzed by fast Fourier transform. No significant time dependent changes in VF characteristics were noted. The peak frequency was highest in control animals and 8‐week MI, intermediate in 5‐day MI, and lowest in acute ischemia (P < 0.01 for pairwise comparisons). In contrast, the fractional of energy within a bandwidth of 25% peak amplitude was highest in acute ischemia, (P < 0.001) and similar in the other three groups. Infarction decreased total energy by approximately 50%. In conclusion, the pressure of ischemia or infarction alters the frequency content of VF in a complex fashion. In addition to decreasing the peak frequency, the shape of the power spectral curve is altered in models of structural heart disease. These results suggest that the electrophysiological changes produced by infarction or ischemia alter the structural organization of ventricular fibrillation.
- 1 November 1999
- Vol. 11 (11) , 700-2
Effect of isoflurane on defibrillation threshold in biphasic active-can defibrillation systems.
In two patients receiving implantable cardioverter-defibrillators (ICD) for spontaneous and inducible ventricular tachyarrhythmias, the use of isoflurane appeared to significantly lower defibrillation thresholds (DFT) at implantation. In the first, at initial implantation and subsequent revision using isoflurane, adequate DFTs were verified by multiple tests. Post-implantation testing using midazolam and fentanyl revealed significantly higher DFTs, necessitating a third operation without isoflurane to obtain an adequate and subsequently verifiable DFT. During the second case, discontinuation of isoflurane intraoperatively resulted in a DFT rise within 25 minutes. In patients receiving general anesthesia for ICD implantation, this possible DFT effect of isoflurane should be recognized.
- 1 November 1999
- Vol. 11 (11) , 700-2
Effect of isoflurane on defibrillation threshold in biphasic active-can defibrillation systems.
In two patients receiving implantable cardioverter-defibrillators (ICD) for spontaneous and inducible ventricular tachyarrhythmias, the use of isoflurane appeared to significantly lower defibrillation thresholds (DFT) at implantation. In the first, at initial implantation and subsequent revision using isoflurane, adequate DFTs were verified by multiple tests. Post-implantation testing using midazolam and fentanyl revealed significantly higher DFTs, necessitating a third operation without isoflurane to obtain an adequate and subsequently verifiable DFT. During the second case, discontinuation of isoflurane intraoperatively resulted in a DFT rise within 25 minutes. In patients receiving general anesthesia for ICD implantation, this possible DFT effect of isoflurane should be recognized.